Alumis ALMS
NASDAQ ALMS
$8.11 +0.21 (+2.66%)
At close: Sep 22, 2026 · 4:00 PM EDT

Alumis (ALMS) Share-based Compensation (2023 - 2026)

Alumis' (ALMS) quarterly Share-based Compensation came in at $152.3 million in Q2 2026, up 717.28% year-over-year from $18.6 million in Q2 2025, and up 130.76% quarter-over-quarter from $66.0 million in Q3 2025.

Analysis

Alumis (ALMS) Share-based Compensation (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Share-based Compensation for 4 consecutive years, with $152.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 717.28% year-over-year to $152.3 million in Q2 2026; TTM through Jun 2026 was $152.3 million, a 335.65% increase from a year earlier, with the FY2025 full-year figure at $238.1 million, up 337.64% from the prior year.
  • Share-based Compensation was $152.3 million for Q2 2026 at Alumis, up from $66.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $152.3 million in Q2 2026 and troughed at $1.9 million in Q2 2023.
  • A 4-year average of $36.4 million and a median of $13.0 million in 2024 frame the typical range for Share-based Compensation.
  • The widest YoY moves for Share-based Compensation: up 2274.86% in 2025, down 57.54% in 2025.
  • Over 4 years, Share-based Compensation stood at $2.3 million in 2023, then jumped by 180.09% to $6.4 million in 2024, then surged by 938.06% to $66.0 million in 2025, then soared by 130.76% to $152.3 million in 2026.
  • The last three Share-based Compensation figures came in at $152.3 million (Q2 2026), $66.0 million (Q3 2025), and $18.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Amgen 221.78 Bn 207.79 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 189.46 Bn 186.20 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.47 Bn 122.62 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 82.64 Bn 74.65 Bn 3.93 Bn 243.00 Mn
5 Moderna 72.84 Bn 67.70 Bn 52.00 Mn 120.00 Mn
6 Argenx Se 59.64 Bn 54.46 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 33.65 Bn 30.35 Bn 992.69 Mn 86.63 Mn
8 Biogen 33.30 Bn 32.01 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 27.62 Bn 28.31 Bn 1.16 Mn 83.34 Mn
10 Alumis 1.01 Bn 506.96 Mn - 152.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152.30 Mn
Sep 30, 2025 66.00 Mn
Jun 30, 2025 18.64 Mn
Mar 31, 2025 63.10 Mn
Dec 31, 2024 6.36 Mn
Sep 30, 2024 7.31 Mn
Jun 30, 2024 43.89 Mn
Mar 31, 2024 2.66 Mn
Sep 30, 2023 2.27 Mn
Jun 30, 2023 1.91 Mn
API Access

Alumis Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALMS&period=max&api_key=YOUR_API_KEY